Cogent Biosciences' announcement of a $125 million public offering of common stock may have a short-term impact on its stock price. The offering could lead to dilution of existing shares, which may cause the stock price to fluctuate. However, the proceeds will be used for general corporate purposes, including research and development, which could have a positive long-term impact on the company's growth and stock price.